BiondVax Pharmaceuticals ...

NASDAQ: BVXV · Real-Time Price · USD
1.36
0.01 (0.74%)
At close: Sep 06, 2023, 9:59 PM

BiondVax Pharmaceuticals Cash Flow Statement

Financials in ILS. Fiscal year is January - December.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Net Income
-3.76M -3.52M 26.86M -12.85M -2.48M -10.75M -9.05M -11.99M
Depreciation & Amortization
147K 138K -1.42M 778K 134K 594K 612K 604K
Stock-Based Compensation
200K 252K n/a 1.3M 485K 2.35M 2.53M 2.58M
Other Working Capital
-3K -349K -4.84M 3.76M 203K 245K 841K -190K
Other Non-Cash Items
1.97M -214K -1.74M -1.34M 237K 1.25M -1.8M 544K
Deferred Income Tax
-765K n/a n/a n/a n/a -52K 4K 24K
Change in Working Capital
-663K 280K -3.27M 1.71M 514K 39K 1.52M 360K
Operating Cash Flow
-2.88M -3.06M 15.85M -10.41M -1.1M -6.52M -6.19M -7.91M
Capital Expenditures
-377K -6K -490K -44K -521K -298K -4K -106K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 7K -40K n/a 42K -9K -1K
Investing Cash Flow
-377K -6K -483K -84K -521K -256K -13K -107K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a 681K n/a n/a 681K -681K n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -25.81M -468K n/a 27.27M -988K -317K
Financial Cash Flow
n/a n/a -25.81M -468K n/a 27.27M -988K -317K
Net Cash Flow
-3.29M -3.29M -12.87M -9.39M -1.99M 19.36M -7.83M -8.69M
Free Cash Flow
-3.25M -3.06M 15.36M -10.45M -1.63M -6.82M -6.19M -8.02M